期刊文献+

PET/CT在非小细胞肺癌放射治疗勾画靶区中的价值 被引量:12

Value of PET / CT in design of irradiation target volume in patients with non-small cell lung cancer
下载PDF
导出
摘要 目的采用PET/CT分析非小细胞肺癌(non-small cell lung cancer,NSCLC)纵隔淋巴结转移特点,为放疗患者勾画靶区提供参考依据。方法375例初治NSCLC患者在治疗前行18F-FDG PET/CT扫描,对不同原发灶部位、分期及病理类型发生纵隔淋巴结转移情况进行统计分析。结果PET/CT结果显示,207例右肺NSCLC纵隔淋巴结转移率由高到低依次为同侧肺门、4R、7、5、2R、10~11L、6区;168例左肺NSCLC纵隔淋巴结转移率依次为同侧肺门淋巴结、5、7、6、4L、4R、10~11R区。中肺和下肺NSCLC的7区转移率显著高于上肺。鳞癌和腺癌纵隔淋巴结转移差异无统计学意义(P〉0.05)。随着患者T分期增加,更容易发生纵隔淋巴结转移。375例NSCLC患者中有88例发生了跳跃式转移,占23.5%。191个跳跃转移区中,4R、7、5、6、2R占有较高比例。纵隔淋巴结跳跃式转移与NSCLC原发灶部位、病理类型及分期无相关性(P〉0.05)。结论PET/CT提示左右肺NSCLC患者纵隔淋巴结转移高危区不同,建议右肺NSCLC放疗靶区应包括10~11R、4R、7、5区;左肺NSCLC放疗靶区应包括10~11L、5、7、6、4L、4R区。 Objective To obtain reference data for designing rational irradiation target volume by the characteristics of mediastinal lymph node metastasis in non-small cell lung cancer (NSCLC) patients by positron emission tomography/computed tomography (PET/CT). Methods The 18F-FDG PET/CT data of 375 NSCLC patients freshly diagnosed by pathology in our hospital from 2012 to 2015 before treatment were collected. The distribution characteristics of mediastinal lymph node metastasis with different lesion location, clinical stage, and pathologic types were analyzed. Results PET/CT scanning indicated that in the 207 patients with right lung NSCLC, the metastasis incidences of mediastinal lymph nodes were decreased as the following order, ipsilateral hilar nodes, 4R, 7, 5, 2R, 10~11L and 6. And for the 168 patients with left lung NSCLC, the highest metastasis incidence of mediastinal lymph nodes was the ipsilateral hilar nodes, followed by 5, 7, 6, 4L, 4R and 10~11R. The metastatic rate of zone 7 area was significantly higher in inferior and middle lobe lung than in the superior lobe lung for the patients. There was no significant differences in the mediastinal lymph node metastasis between the squamous carcinoma and adenocarcinoma (P〉0.05). With the increasing of T stage, the patients were prone to mediastinal lymph node metastasis. There were 88 patients having skip metastasis among the 375 patients, accounting for 23.5%. In the 191 skip metastasis areas, 4R, 7, 5, 6 and 2R had higher percentages. Mediastinal lymph nodes metastasis had no correlation with location, pathological type and stage in primary lung lesion P〉0.05). Conclusion PET/CT results indicate that the high risk metastatic areas are different in the right and left NSCLC, and clinical irradiation target volume should include zones 10~11R, 4R, 7 and 5 for the patients of right lung NSCLC, and 10~11L, 5, 7, 6, 4L and 4R.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第5期501-505,共5页 Journal of Third Military Medical University
基金 第三军医大学临床创新基金(SWH2013LC19)~~
关键词 非小细胞肺癌 纵隔淋巴结转移 PET/CT 放疗靶区 non-small cell lung cancer mediastinal lymph node metastasis PET/CT radiotherapy target volume
  • 相关文献

参考文献15

  • 1Rosenzweig K R,Sura S,Jackson A, et al. Involved-field ra-diation therapy for inoperable non small-cell lung cancer [ J ].J Clin Oncol,2007, 25(35) : 5557 -5561. DOI: 10.1200/JC0.2007. 13.2191.
  • 2高昂,孟雪,岳金波,等.FDGPET/CT指导非小细胞肺癌剂量提升靶区勾画的研究[C]//第八届中国肿瘤学术大会暨第十三届海峡两岸肿瘤学术会议论文汇编,2014.
  • 3Silvestri G A, Gonzalez A V,Jantz M A,et al. Methods forstaging non-small cell lung cancer : diagnosis and managementof lung cancer, 3rd ed: American College of Chest Physiciansevidence-based clinical practice guidelines[ J]. Chest, 2013,143(5 Suppl) : e211S - e250S. DOI: 10. 1378/chest. 12-2355.
  • 4Ceylan N, Dogan S, Kocacelebi K, et al. Contrast enhancedCT versus integrated PET-CT in pre-operative nodal staging ofnon-small cell lung cancer[ J]. Diagn Interv Radiol,2012 18(5): 435 -440. DOI: 10.4261/1305-3825. DIR. 5100-11. 2.
  • 5Zheng Y, Sun X, Wang J,et al. FDG-PET/CT imaging fortumor staging and definition of tumor volumes in radiationtreatment planning in non-small cell lung cancer [ J ]. OncolLett, 2014,7(4) ; 1015 - 1020. DOI: 10. 3892/ol. 2014.1874.
  • 6Rusch V W, Asamura /-I, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer [ J ]. J Thorac Oncol, 2009, 4 ( 5 ) : 568 - 577. DOI: 10. 1097/JTO. 0b013e3181 a0d82e.
  • 7Park H K, Jeon K, Koh W J, ef al. Occult nodal metastasisin patients with non-small cell lung cancer at clinical stage IAby PET/CT[J]. Respirology, 2010,15(8) : 1179 - 1184.DOI : 10.1111/j. 1440 -1843. 2010. 01793. x.
  • 8Li X, Zhang H,Xing L,et al. Mediastinal lymph nodes stag-ing by 18F-FDG PET/CT for early stage non-small cell lungcancer: a multicenter study[ J]. Radiother Oncol, 2012, 102(2): 246-250. DOI: 10. 1016/j. radonc. 2011. 10.016.
  • 9段晓蓓,樊卫,许泽清,陈相猛.基于^(18)F-FDG PET/CT显像分析非小细胞肺癌纵隔淋巴结转移的危险因素[J].中国医学影像技术,2012,28(6):1135-1139. 被引量:14
  • 10张连民,张真发,王长利.ⅢA-N2期非小细胞肺癌纵隔淋巴结跳跃式转移的临床和预后分析[J].中华外科杂志,2010,48(10):780-783. 被引量:16

二级参考文献45

  • 1王长利,尤健,孙承军,姜宏景,张熙曾.肺癌胸内淋巴结转移规律及其临床意义[J].中国肺癌杂志,2004,7(5):438-441. 被引量:27
  • 2包勇,陈明,王卫华,郑列,卢泰祥,崔念基.CT横断面上肺癌淋巴引流区域的界定及勾画[J].中国癌症杂志,2006,16(6):467-471. 被引量:6
  • 3郑列,沈静娴,吴沛宏,谢传淼,莫运仙,阮超美,刘学文,戎铁华,王欣,张仕义.螺旋CT对非小细胞肺癌纵隔淋巴结分期的诊断价值[J].中国肿瘤临床,2006,33(12):693-695. 被引量:7
  • 4Martini N,Flehniger BJ,Zaman MB,et al.Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases.Ann Surg,1983,198:386-397.
  • 5Rami-Porta R,Ball D,Crowley J,et al.The IASLC Lung Cancer Staging Project:proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.J Thorac Oncol,2007,2:593-602.
  • 6Nanike T,Suemasu K,Ishikawa S.Lymph node mapping and curability at various levels of metastasis in resected lung cancer.J Thorac Cardiovasc Surg,1978,76:832-839.
  • 7Mountain CF,Dresler CM.Regional lymph node classifcation for lung cancer staging.Chest,1997,111:1718-1723.
  • 8Bonner JA,Garces YI,Sawyer TE,et al.Frequency of noncontiguous lymph node involvement in patients withespectable nonsmall cell lung carcinoma.Cancer,1999,86:1159-1164.
  • 9Riquet M,Hidden G,Debesse B.Direct lymphatic drainage of lung segments to mediastinal nodes.An anatomic study on 260 adults.J Thorac Cardiovasc Surg,1989,97:623-632.
  • 10Misthos P,Sepsas E,Athanassiadi K,et al.Skip metastases:analysis of their clinical significance and prognosis in the Ⅲ A stage of non-small cell lung cancer.Eur J Cardiothorac Surg,2004,25:502-508.

共引文献32

同被引文献114

引证文献12

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部